Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Breast Neoplasms × talimogene laherparepvec × Clear all

Phase

Phase 1 2 Phase EARLY_PHASE1 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Letrozole 7 Fluorodeoxyglucose F18 7 Magnetic Resonance Spectroscopy 5 Blood Specimen Collection 5 pembrolizumab 4 atezolizumab 4 Trastuzumab 4 palbociclib 3 Oncolytic Virotherapy 3 Fish Oils 3 Docosahexaenoic Acids 3 Carboplatin 3 Biopsy 3 Bevacizumab 3 pertuzumab 2 Vitamin D 2 Vinorelbine 2 Taxes 2 Sentinel Lymph Node Biopsy 2 Saline Solution 2 Radiotherapy 2 Positron Emission Tomography Computed Tomography 2 Paclitaxel 2 Omacor 2 Neoadjuvant Therapy 2 Metformin 2 Lapatinib 2 Fulvestrant 2 Denosumab 2 Cyclophosphamide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03802604 2025-09-09

PROMETEO

SOLTI Breast Cancer Research Group

Phase EARLY_PHASE1 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡